TrialNature medicine2026

Fecal microbiota transplantation plus pembrolizumab and axitinib in metastatic renal cell carcinoma: the randomized phase 2 TACITO trial.

Serena Porcari et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.